<\/a>
\n\t\t\t\t\t\t
\n\t\t\t\t\t<\/div><\/div><\/div>\n\t\t\tLed by new investor NGN Capital, the round drew large participation from all existing investors, including Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie, as well as multiple employees. As part of the financing activity, NGN Capital Managing General Partner Peter Johann, Ph.D. has joined the Endosense board of directors.<\/p>\n
Proceeds will be used to support the growth of a new direct sales organization in Europe; commercialization of the recently introduced third-generation TactiCath Quartz forcesensing catheter in the region; development of next generation products; completion of the TOCCASTAR investigational device exemption (IDE) clinical study follow-up and FDA approval submission for the TactiCath; and, the launch of the device in the United States.<\/p>\n
Founded in Geneva in 2003, Endosense is a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. The company pioneered the use of contact-force measurement in catheter ablation with the development of the TactiCath, the first force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. <\/p>\n
Ysios Capital Partners manages Ysios BioFund I, \u2013founded in 2008 with a total amount of \u20ac69 million\u2013 and has nine portfolio companies: MedLumics (Madrid), AM-Pharma BV (Bunnik, The Netherlands), STAT Diagnostica (Barcelona), Sabirmedical (Barcelona), Cardoz (Stockholm, Sweden), Endosense (Geneva), Biovex (now Amgen, Boston) and Cellerix (Madrid, now Tigenix NV NYSE Alternext:TIG). <\/p>\n","protected":false},"excerpt":{"rendered":"
Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the close of a \u20ac30million Series C financing, making it one of the largest rounds of funding in medical technology to be held in Europe. Led by new investor NGN Capital, the round drew large participation from all existing investors, including Ysios Capital Partners. This Spanish venture capital firm \u2013based in the Barcelona Science Park\u2013 has invested in a total of 9 healthcare and biotechnology companies, with special focus on pharmaceuticals and medical devices, through its first fund Ysios BioFund I<\/i> of \u20ac 69 million.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-48182","post","type-post","status-publish","format-standard","category-uncategorized"],"acf":[],"yoast_head":"\nYsios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ysios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the close of a \u20ac30million Series C financing, making it one of the largest rounds of funding in medical technology to be held in Europe. Led by new investor NGN Capital, the round drew large participation from all existing investors, including Ysios Capital Partners. This Spanish venture capital firm \u2013based in the Barcelona Science Park\u2013 has invested in a total of 9 healthcare and biotechnology companies, with special focus on pharmaceuticals and medical devices, through its first fund Ysios BioFund I of \u20ac 69 million.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-28T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-18T13:52:51+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Ysios Capital Partners participates in the \u20ac30million financing of Endosense\",\"datePublished\":\"2012-11-28T23:00:00+00:00\",\"dateModified\":\"2020-11-18T13:52:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/\"},\"wordCount\":249,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1354185283671.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/\",\"name\":\"Ysios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1354185283671.jpg\",\"datePublished\":\"2012-11-28T23:00:00+00:00\",\"dateModified\":\"2020-11-18T13:52:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1354185283671.jpg\",\"contentUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1354185283671.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ysios Capital Partners participates in the \u20ac30million financing of Endosense\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ysios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/","og_locale":"en_US","og_type":"article","og_title":"Ysios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona","og_description":"Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the close of a \u20ac30million Series C financing, making it one of the largest rounds of funding in medical technology to be held in Europe. Led by new investor NGN Capital, the round drew large participation from all existing investors, including Ysios Capital Partners. This Spanish venture capital firm \u2013based in the Barcelona Science Park\u2013 has invested in a total of 9 healthcare and biotechnology companies, with special focus on pharmaceuticals and medical devices, through its first fund Ysios BioFund I of \u20ac 69 million.","og_url":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2012-11-28T23:00:00+00:00","article_modified_time":"2020-11-18T13:52:51+00:00","og_image":[{"url":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg","type":"","width":"","height":""}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Written by":"adminpcb","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Ysios Capital Partners participates in the \u20ac30million financing of Endosense","datePublished":"2012-11-28T23:00:00+00:00","dateModified":"2020-11-18T13:52:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/"},"wordCount":249,"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/","url":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/","name":"Ysios Capital Partners participates in the \u20ac30million financing of Endosense - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg","datePublished":"2012-11-28T23:00:00+00:00","dateModified":"2020-11-18T13:52:51+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#primaryimage","url":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg","contentUrl":"http:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/11\/1354185283671.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/en\/ysios-capital-partners-participates-in-the-e30million-financing-of-endosense\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"Ysios Capital Partners participates in the \u20ac30million financing of Endosense"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/48182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=48182"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/48182\/revisions"}],"predecessor-version":[{"id":52372,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/48182\/revisions\/52372"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=48182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=48182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=48182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}